u/emil_marchand

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

no price talk, no tickers, no investment discussion

fertility signal is there but unclear

Yeah, the lane data is more useful than single reports.

the VendorInvestigate and Medutest results differ by 20 points, both inside inter-lab variance

Which network and did the vendor confirm they credit it?

the tier 3 pathway is the only free route, it is slow

inter-lab variance is real, 17 points is inside normal

Poland to Poland: QSC with 10 days is the average, variance is 32

This is the "correlation is mechanism" thing again. You changed three variables at once.

This result fits the template perfectly.

Disagree on that part. 98.7% and 99.0% on the same vial is normal.

gas versus discount arithmetic is real

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

How many weeks between the two measurements?

data logger is the standard, gut feeling is not

Strongly agree. NHS is region-specific.

I am going to push back on this slightly.

The tier 3 pathway in my area: 15 month wait, then 12 months for review, then approved. Total pharmacy.

private prescription routes vary by region

Disagree on that part. 97.9% and 97.6% on the same vial is normal.

price posts need the date — UK pricing moves monthly